ENCAB987FLC
Antibody against Homo sapiens NCBP1
Homo sapiens
HepG2
characterized to standards
Homo sapiens
any cell type or tissue
partially characterized
- Status
- released
- Source (vendor)
- MBLI
- Product ID
- RN103PW
- Lot ID
- 001
- Characterized targets
- NCBP1 (Homo sapiens)
- Host
- rabbit
- Clonality
- polyclonal
- External resources
Characterizations
NCBP1 (Homo sapiens)
HepG2
Method: immunoprecipitation
compliant
- Caption
- IP-Western Blot analysis of HepG2 whole cell lysate using NCBP1 specific antibody. Lane 1 is 1% of twenty million whole cell lysate input and lane 2 is 25% of IP enrichment using rabbit normal IgG (lanes under 'IgG'). Lane 3 is 1% of twenty million whole cell lysate input and lane 4 is 10% IP enrichment using rabbit polyclonal anti-NCBP1 antibody (lanes under 'NCBP1').
- Submitted by
- Steven Blue
- Lab
- Gene Yeo, UCSD
- Grant
- U54HG007005
- Download
- HepG2_MBLI_RN103PW_001_NCBP1.png
NCBP1 (Homo sapiens)
Method: immunoprecipitation
not submitted for review by lab
- Caption
- IP-WB analysis of K562 whole cell lysate using NCBP1 specific antibody. Lane 1 is 2.5% of five million whole cell lysate Input, lane 2 is 2.5% of supernatant after immunoprecipitation and Lane 3 is 50% of IP enrichment using rabbit polyclonal Anti-NCBP1 (CBP80) pAb. This antibody passes preliminary validation and will be further pursued for primary and secondary validation.
- Submitted by
- Balaji Sundararaman
- Lab
- Gene Yeo, UCSD
- Grant
- U54HG007005
- Download
- MBLI_RN103PW_001_NCBP1.png
NCBP1 (Homo sapiens)
Method: knockdown or knockout
compliant
- Caption
- Western blot following CRISPR against NCBP1 in HepG2 whole cell lysate using NCBP1 specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against NCBP1.NCBP1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.
- Submitted by
- Xintao Wei
- Lab
- Brenton Graveley, UConn
- Grant
- U41HG009889
- Download
- NCBP1-HEPG2-CRISPR.png
NCBP1 (Homo sapiens)
Method: knockdown or knockout
compliant
- Caption
- Western blot following CRISPR against NCBP1 in K562 whole cell lysate using NCBP1 specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against NCBP1. NCBP1 protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.
- Submitted by
- Xintao Wei
- Lab
- Brenton Graveley, UConn
- Grant
- U41HG009889
- Download
- NCBP1-K562-CRISPR.png